PetLife Pharmaceuticals Hires InnoVision Therapeutics in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
PetLife Pharmaceuticals Hires InnoVision Therapeutics in Preparation of Vitalzul™ FDA Submission

HANCOCK, Md., Aug. 25, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTCQB:PTLF) (the "Company") , a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, is pleased to announce the signing of a contract with InnoVision Therapeutics, a major step towards the Center for Veterinary Medicine (CVM)/FDA testing and approval process for Vitalzul™.

PetLife, having already made a deposit with InnoVision, will immediately begin pre-INAD studies (Investigational New Animal Drug) of Vitalzul™ with InnoVision Therapeutics.

InnoVision will work with the company to set up an initial meeting with the CVM to present and refine the regulatory pathway. Experts estimate that it will take between 18-24 months to complete the necessary pre-clinical and clinical studies needed for final FDA review.

Vitalzul™ is a new pet oncological treatment, based on Escozine, a blue scorpion venom treatment, which has been used for years to treat humans with cancer in many countries with no signs of toxicity or complications during clinical use. With its ease of administering and significantly lower cost than traditional treatments, PetLife is excited about its new Vitalzul™ product line and expects strong market acceptance.

“We are pleased to be working with PetLife Pharmaceuticals. Our great success with Escozine as a therapeutic drug in Humans will be of great benefit to PetLife's Vitalzul™ CVM/FDA process,” stated Dr. Mishra, Managing Director of InnoVision Therapeutics.

Dr. Salvagno, CEO of PetLife Pharmaceuticals, comments on the company's progress "We are delighted that InnoVision is taking PetLife on as a new client. Navigating the CVM/FDA waters is challenging and InnoVision's experience will facilitate smooth travels. Moving our process forward opens up a new frontier in the ongoing oncological battle in pets, providing for less expensive and more effective treatment methods.”

Petlife Pharmaceuticals will be presenting Vitalzul™ at the San Francisco Money Show: August 23-25, 2016.

Petlife’s 506 Private Placement Memorandum is available only to accredited investors.

About InnoVision Therapeutics InnoVision Therapeutics recognizes the vast potential of early stage Drug discovery and biological research, but realizes that it is only with the careful design and implementation of a sound development plan will this potential be realized. InnoVision Therapeutics experienced management team, Scientific Advisory Board and Board of Directors, apply a complex and rigorous screening process in order to determine which projects will be accepted. Once a project is accepted InnoVision Therapeutics designs a comprehensive drug development plan and assumes full responsibility for its progress and success. Throughout the process, InnoVision Therapeutics strives to maintain strong involvement of the inventors, companies and universities as partners in the drug development program. InnoVision Therapeutics is continuously seeking new therapeutic projects for a wide array of indications by partnering with innovative researchers and pharmaceutical companies to further develop their compounds to maximize the opportunity to create effective and marketable therapies.

For more information about InnoVision Therapeutics, please visit their website: http://www.innovision-pharma.com/

About Center for Veterinary Medicine (CVM) The Center for Veterinary Medicine protects public and animal health by ensuring that animal drugs and medicated feeds are safe and effective and that food from treated animals is safe to eat. The responsibilities of CVM have a direct effect on the safety of the human food supply and on the safety to animals that are treated with veterinary products.

CVM regulates drugs, devices, and food additives for over 100 million companion animals, plus millions of poultry, cattle, swine, and minor animal species. (Minor animal species include animals other than cattle, swine, chickens, turkeys, horses, dogs, and cats.) For additional information, please visit: http://www.fda.gov/aboutfda/centersoffices/of...efault.htm

About PetLife Pharmaceuticals, Inc. PetLife Pharmaceuticals (OTCQB:PTLF) ( http://www.PetLifePharma.com ) is a registered US Veterinary Pharmaceutical company, incorporated in 2012.

PetLife's mission is to bring its new, scientifically proven, non-toxic, potentiated bioactive nutraceuticals and prescription medication to the world of veterinary oncology -- with the ultimate goal of preventing cancer and extending the life of pets suffering from cancer while improving their quality of life. In the US alone, consumer spending on domestic companion animals reached over $60 billion in 2015 with over $29 billion spent on veterinary care and medications.

Safe Harbor

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: PetLife encourages those interested in our Company to rely only on information included in our filings with the United States Securities and Exchange Commission which can be found at www.sec.gov . Statements released by the Company, that are not purely historical are forward-looking within the meaning of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's expectations, hopes, intentions, and strategies for the future. Investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the Company's business prospects and performance. The Company's actual results could differ materially from those in such forward-looking statements. Risk factors include but are not limited to general economic, competitive, governmental, and technological factors as discussed in the Company's filings with the SEC on Forms 10-K, 10-Q, and 8-K. The Company does not undertake any responsibility to update the forward-looking statements contained in this release.

 

Investor Relations: Invicto Group info@invictogroup.com 800-928-7462 Ext. 801

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SAP Execution Can Steady Operations Beyond Spreadsheets

Updated Category News Views 87

Spreadsheets breed little kingdoms, and SAP is often left outside the gate. That is the operational mess Martin Rowan, managing partner at Reveal USA, Inc. in Naperville, is taking aim at in a Nov. 19, 2026 HelloNation feature. His central point is not terribly glamorous, but it is dead right: a company gets less stable when it uses SAP to explain yesterday's results...

Continue Reading
TNBC Advocate Campaign Targets Gaps in Patient Clarity

Updated Category News Views 93

Triple-negative is a heavy phrase to hand somebody without a map. Tigerlily Foundation and the Breast Cancer Resource Center are trying to close that gap with a national education campaign scheduled to launch publicly on January 11, 2027. The plan is straightforward on paper: train and mobilize 100 patient advocates across the country to explain triple-negative breast...

Continue Reading
EmTech AI 2027 Puts AI Ambitions Through Reality Test

Updated Category News Views 111

A three-day gathering cannot settle AI's biggest arguments, but MIT Technology Review has picked the right fight for EmTech AI 2027: make the industry face a Reality Test. The conference runs May 11–13, 2027, at MIT's campus and online, and that theme lands because the AI conversation has spent plenty of time admiring the engine while skipping the ugly maintenance bill....

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 108

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 87

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
SKINformed Bets on Skin Longevity Over Quick Fixes

Updated Category News Views 75

Wrinkle panic has been a very profitable racket for a long time, and SKINformed is trying to sidestep it. The physician-founded skincare brand is planting its flag on “SKINgevity,” a term it uses to describe long-term skin health rather than a frantic hunt for an overnight rewind. That is a sensible read on where beauty consumers appear to be headed: less appetite for...

Continue Reading
AI Forces Learning Teams to Redefine Their Core Job

Updated Category News Views 89

Training Departments Are Not Sitting Still Corporate learning has spent years being treated like the office instruction manual, and AI is making that old arrangement look awfully flimsy. RedThread Research's November 19, 2026 study lands on a point that ought to make senior management pay attention: learning and development leaders are not merely waiting around to be...

Continue Reading
PostalAnnex Adds Roseville Store as Owners Reach Three

Updated Category News Views 97

A third storefront from the same operators says more than a ribbon-cutting ever will. Aarondeep Hira and Manraj Sangha have opened a PostalAnnex in Roseville, California, their third Sacramento-area location after earlier operations in Sacramento and Antelope. For a franchise system, repeat ownership is the part worth noticing. It is not a guarantee of booming sales, and...

Continue Reading
Corner Bakery Bets on Holiday Catering Convenience

Updated Category News Views 128

A $50 carrot on a $350 catering tab tells you exactly where Corner Bakery sees the holiday battlefield: not in one lonely cookie sale, but in the larger group order that can make a restaurant’s day. The chain is pushing holiday catering through November and December, pairing that discount with bakery trays, meals for groups and a promise to handle delivery setup. It is...

Continue Reading
Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 118

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading

Top 5 Most Recently Viewed Articles

Transparency in Securities Disclosure: Learning Technologies' Interest

Updated Category News Views 111

Key Information About Securities Disclosure In the evolving landscape of financial regulations, transparency stands as a foundational requirement for public companies. One of the pivotal rules governing such disclosures is laid out in Rule 8.3 of the Takeover Code. This rule mandates that entities or individuals with interests in relevant securities of 1% or more must...

Continue Reading
Chart Industries Inc. Reports Impressive Q2 Performance

Updated Category News Views 115

Exceptional Financial Growth in Q2 Chart Industries, Inc. (NASDAQ: GTLS) shared its financial results for the second quarter. The company witnessed notable growth compared to the previous year's quarter, marking a significant trajectory in its market position. Quarterly Highlights In the second quarter, Chart Industries recorded orders totaling $1.50 billion, representing...

Continue Reading
Marine Lubricants Market Growth Forecast: USD 7.8 Billion

Updated Category News Views 70

Overview of the Marine Lubricants Market The marine lubricants market is steadily growing, with forecasts estimating its value will reach an impressive USD 7.8 billion by 2032. This growth is driven by a compound annual growth rate (CAGR) of 2.07% during the period from 2024 to 2032. Key Drivers Behind Market Growth One of the main factors fueling this market's growth is...

Continue Reading
Celebrating Diversity in Arbitration: CCA’s New Class Announced

Updated Category News Views 185

Celebrating Diversity with New CCA Associates Class The College of Commercial Arbitrators (CCA) is thrilled to introduce the new class of Associates for the 2025–2027 mentorship program. This initiative, started in 2022, highlights the CCA's commitment to nurturing emerging talent in the field of commercial arbitration, particularly from underrepresented backgrounds. By...

Continue Reading
Big Bronze Unveils Final K9 Statue to Honor Veterans

Updated Category News Views 211

Big Bronze Completes Veteran's Memorial with Final K9 Statue Big Bronze, renowned for its exquisite bronze sculptures, is thrilled to share the news of completing an important project at Veterans Memorial Park. This milestone marks the addition of the fourth and final statue in a series designed to honor the sacrifices of U.S. veterans. A Tribute to Valor and Sacrifice...

Continue Reading